These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24411027)

  • 1. MicroRNAs regulate several functions of normal tissues and malignancies.
    Wen KC; Sung PL; Yen MS; Chuang CM; Liou WS; Wang PH
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):465-9. PubMed ID: 24411027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer.
    Eini R; Dorssers LC; Looijenga LH
    Int J Dev Biol; 2013; 57(2-4):319-32. PubMed ID: 23784843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
    FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
    Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
    Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MicroRNAs: a new class of gene expression regulators].
    Hartmann C; Corre-Menguy F; Boualem A; Jovanovic M; Lelandais-Brière C
    Med Sci (Paris); 2004 Oct; 20(10):894-8. PubMed ID: 15461967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Ovarian Cancer.
    Katz B; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-128 and its target genes in tumorigenesis and metastasis.
    Li M; Fu W; Wo L; Shu X; Liu F; Li C
    Exp Cell Res; 2013 Dec; 319(20):3059-64. PubMed ID: 23958464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profile during adipogenic differentiation in mouse embryonic stem cells.
    Knelangen JM; van der Hoek MB; Kong WC; Owens JA; Fischer B; Santos AN
    Physiol Genomics; 2011 May; 43(10):611-20. PubMed ID: 21245416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcoma.
    Sun R; Shen JK; Choy E; Yu Z; Hornicek FJ; Duan Z
    Discov Med; 2015 Nov; 20(111):311-24. PubMed ID: 26645903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the potential use of microRNAs as biomarker in cancer.
    Anindo MI; Yaqinuddin A
    Int J Surg; 2012; 10(9):443-9. PubMed ID: 22906693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
    J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and diagnostic role of microRNAs in ovarian carcinoma.
    Davidson B; Tropé CG; Reich R
    Gynecol Oncol; 2014 Jun; 133(3):640-6. PubMed ID: 24713546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
    Lowery AJ; Miller N; McNeill RE; Kerin MJ
    Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.